Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Aggressive
disability
highly active
multiple sclerosis
observational studies
relapsing/remitting
Journal
Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185
Informations de publication
Date de publication:
12 06 2020
12 06 2020
Historique:
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
13
6
2020
Statut:
aheadofprint
Résumé
While the major phenotypes of multiple sclerosis (MS) and relapsing-remitting, primary and secondary progressive MS have been well characterized, a subgroup of patients with an active, aggressive disease course and rapid disability accumulation remains difficult to define and there is no consensus about their management and treatment. The current lack of an accepted definition and treatment guidelines for aggressive MS triggered a 2018 focused workshop of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) on aggressive MS. The aim of the workshop was to discuss approaches on how to describe and define the disease phenotype and its treatments. Unfortunately, it was not possible to come to consensus on a definition because of unavailable data correlating severe disease with imaging and molecular biomarkers. However, the workshop highlighted the need for future research needed to define this disease subtype while also focusing on its treatment and management. Here, we review previous attempts to define aggressive MS and present characteristics that might, with additional research, eventually help characterize it. A companion paper summarizes data regarding treatment and management.
Identifiants
pubmed: 32530385
doi: 10.1177/1352458520925369
pmc: PMC7412876
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1352458520925369Investigateurs
Maria Pia Amato
(MP)
Arrambide Georgina
(A)
Joseph Berger
(J)
Alexey Boyko
(A)
Vesna Brinar
(V)
Wallace Brownlee
(W)
Lou Brundin
(L)
Olga Ciccarelli
(O)
Alasdair Coles
(A)
Jorge Correale
(J)
Gary Cutter
(G)
Tobias Derfuss
(T)
Gilles Edan
(G)
Nikolaos Evangelou
(N)
Oscar Fernandez
(O)
Jette Frederiksen
(J)
Ralf Gold
(R)
Yael Hacohen
(Y)
Hans-Peter Hartung
(HP)
Kerstin Hellwig
(K)
Bernhard Hemmer
(B)
Jan Hillert
(J)
Ellen Iacobaeus
(E)
Jaime Imitola
(J)
Tomas Kalincik
(T)
Ludwig Kappos
(L)
Samia Khoury
(S)
Ho Jin Kim
(HJ)
Eva Kubala Havrdová
(E)
Roland Liblau
(R)
Jan Lycke
(J)
Xavier Montalban
(X)
Paolo Muraro
(P)
Stephen Reingold
(S)
Klaus Schmierer
(K)
Finn Sellebjerg
(F)
Per Soelberg Sørensen
(P)
Alessandra Solari
(A)
Maria Pia Sormani
(MP)
Alan Thompson
(A)
Mar Tintore
(M)
Bruce Trapp
(B)
Helen Tremlett
(H)
Maria Trojano
(M)
Carmen Tur
(C)
Antonio Uccelli
(A)
Vincent van Pesch
(V)
Sandra Vukusic
(S)
Emmanuelle Waubant
(E)
Références
PLoS One. 2010 Aug 05;5(8):e11986
pubmed: 20700489
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Brain. 2015 Jul;138(Pt 7):1863-74
pubmed: 25902415
Nat Rev Neurol. 2015 Jul;11(7):379-89
pubmed: 26032396
Brain. 2003 Apr;126(Pt 4):770-82
pubmed: 12615637
Ann Neurol. 2013 Mar;73(3):341-54
pubmed: 23463494
J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):300-6
pubmed: 7897410
Neurol Neuroimmunol Neuroinflamm. 2016 Sep 07;3(5):e279
pubmed: 27648465
Neurology. 2011 Jun 7;76(23):1996-2001
pubmed: 21646626
Mult Scler. 2017 Mar;23(3):456-463
pubmed: 27325603
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48
pubmed: 27640924
Neurology. 2015 Feb 24;84(8):784-93
pubmed: 25632085
Ann Clin Transl Neurol. 2015 May;2(5):479-91
pubmed: 26000321
Mult Scler. 2019 Jul;25(8):1102-1112
pubmed: 29911467
Mult Scler. 2013 Dec;19(14):1878-86
pubmed: 23652215
Neurology. 2010 Nov 23;75(21):1933-8
pubmed: 21098409
Mult Scler. 2017 Apr;23(5):665-674
pubmed: 27481210
Mult Scler. 2019 Oct 15;:1352458519877810
pubmed: 31610739
J Neuroimmunol. 2010 Mar 30;220(1-2):120-4
pubmed: 20117844
Mult Scler. 2017 Feb;23(2):266-276
pubmed: 27055805
Ann Clin Transl Neurol. 2018 Oct 16;5(12):1478-1491
pubmed: 30564615
Ann Neurol. 2006 Aug;60(2):236-42
pubmed: 16786526
J Neuroimaging. 2018 Nov;28(6):556-586
pubmed: 30102003
Nat Rev Neurol. 2019 Jan;15(1):53-58
pubmed: 30315270
J Neurol Sci. 2009 Jul 15;282(1-2):39-46
pubmed: 19168189
Mult Scler. 2018 Mar;24(3):301-312
pubmed: 28301287
Brain. 2019 Aug 1;142(8):2276-2287
pubmed: 31342055
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1192-8
pubmed: 23744892
Ann Neurol. 2005 Jul;58(1):50-7
pubmed: 15912506
N Engl J Med. 1998 Jan 29;338(5):278-85
pubmed: 9445407
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21
pubmed: 24554104
Lancet Neurol. 2014 Sep;13(9):936-48
pubmed: 25142460
Mult Scler. 2019 Dec;25(14):1915-1925
pubmed: 30566027
Neurology. 1996 Apr;46(4):907-11
pubmed: 8780061
PLoS One. 2018 Oct 23;13(10):e0206140
pubmed: 30352103
Mult Scler. 2011 Mar;17(3):335-43
pubmed: 21135023
Neurology. 2018 Jun 12;90(24):e2107-e2118
pubmed: 29769373
Neuropsychiatr Dis Treat. 2016 Aug 01;12:1907-12
pubmed: 27536112
Arch Neurol. 2001 Jan;58(1):65-70
pubmed: 11176938
Brain. 2015 Apr;138(Pt 4):918-31
pubmed: 25688078
Mult Scler. 2008 Nov;14(9):1208-13
pubmed: 18755821
Brain. 2018 Aug 1;141(8):2382-2391
pubmed: 29860296
Neurology. 2014 Jul 15;83(3):278-86
pubmed: 24871874
Front Neurol. 2019 May 03;10:459
pubmed: 31130911
Brain. 2016 Jan;139(Pt 1):39-46
pubmed: 26667278
J Clin Invest. 2014 Mar;124(3):1168-72
pubmed: 24531550
Brain. 2010 Jul;133(Pt 7):1914-29
pubmed: 20534650
Arch Neurol. 2006 Dec;63(12):1686-91
pubmed: 17172607
Eur J Hum Genet. 2010 May;18(5):618-20
pubmed: 19935835
Mult Scler. 2010 Jan;16(1):62-7
pubmed: 19995837
Mult Scler. 2002 Aug;8(4):295-8
pubmed: 12166499
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):872-7
pubmed: 12810770
Lancet Neurol. 2003 Dec;2(12):747-56
pubmed: 14636780
Mult Scler. 2019 Aug 2;:1352458519864933
pubmed: 31373535
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109-15
pubmed: 24554101
JAMA. 2015 Jan 20;313(3):275-84
pubmed: 25602998
Ann Neurol. 2008 Sep;64(3):247-54
pubmed: 18570297
Mult Scler. 2019 Nov 4;:1352458519885613
pubmed: 31680621
Mult Scler. 2012 Jun;18(6):825-34
pubmed: 22383228
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Ann Neurol. 2008 Sep;64(3):255-65
pubmed: 18661561
Mult Scler. 2018 Feb;24(2):96-120
pubmed: 29353550
Mult Scler. 2018 Mar;24(3):322-330
pubmed: 28287331
J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1344-50
pubmed: 21436229
Neurology. 2001 Oct 9;57(7):1248-52
pubmed: 11591844
Neuroradiology. 2012 Jan;54(1):5-12
pubmed: 21327771
J Neuroinflammation. 2017 Jan 17;14(1):11
pubmed: 28095856
J Neuroinflammation. 2018 Jul 18;15(1):209
pubmed: 30021640
Immunology. 2013 Oct;140(2):211-9
pubmed: 23721329
Brain. 2006 Jan;129(Pt 1):200-11
pubmed: 16280350
J Neurol Sci. 2001 Aug 15;189(1-2):13-21
pubmed: 11535229
J Neurol Sci. 1999 Oct 15;168(2):96-106
pubmed: 10526190
Mult Scler. 2010 Mar;16(3):287-92
pubmed: 20086018
Neurology. 2001 Feb 13;56(3):312-6
pubmed: 11171894
Mult Scler Relat Disord. 2019 May;30:215-224
pubmed: 30822617
Clin Exp Immunol. 2017 Sep;189(3):268-278
pubmed: 28498568
JAMA Neurol. 2019 Jul 1;76(7):841-849
pubmed: 31034002
Lancet. 2016 Aug 6;388(10044):576-85
pubmed: 27291994
Neurology. 1996 Dec;47(6):1469-76
pubmed: 8960729
J Neurol Sci. 2010 May 15;292(1-2):52-6
pubmed: 20202650
Front Immunol. 2018 May 07;9:834
pubmed: 29867923
Brain. 1991 Apr;114 ( Pt 2):1045-56
pubmed: 2043940
Ann Neurol. 2018 Feb;83(2):210-222
pubmed: 29331092
Genes Immun. 2002 Feb;3(1):53-5
pubmed: 11857064
Brain. 2009 Jan;132(Pt 1):250-9
pubmed: 19022862
Brain. 2000 Jun;123 ( Pt 6):1174-83
pubmed: 10825356
Nat Commun. 2018 Dec 17;9(1):5337
pubmed: 30559390